Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
declopramide | muscarinic acetylcholine receptor m1 | NA | Successful target | TTD | Inflammatory Bowel Diseases[MeSHID:D015212] Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
declopramide | dopamine d2 receptor | NA | Successful target | TTD | Inflammatory Bowel Diseases[MeSHID:D015212] Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | discontinued in phase 2 | unknown |
declopramide | dna topoisomerase 2-alpha | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
declopramide | dna topoisomerase 2-beta | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
declopramide | dna | small molecule | NA | drugbank | Inflammatory Bowel Diseases[MeSHID:D015212] Colorectal Cancer[MeSHID:D015179] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigational | unknown |
click here to return to the previous page |